Dynamic Medical Technologies (4138) — Cash Flow Reinvestment Rate
Dynamic Medical Technologies (4138) has a Cash Flow Reinvestment Rate of 0.21x as of December 2025, reinvesting NT$52.66 Million (capex NT$3.73 Million plus investments NT$48.93 Million) from operating cash flow of NT$246.38 Million. See 4138 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dynamic Medical Technologies Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Dynamic Medical Technologies across 10 annual periods. For the full cash flow conversion analysis, see Dynamic Medical Technologies (4138) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Dynamic Medical Technologies (2016–2025)
Year-by-year capital reinvestment analysis for Dynamic Medical Technologies. See 4138 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.43x | NT$134.63 Million | NT$314.86 Million | NT$52.15 Million | ▼ -24.5% |
| 2024 | 0.57x | NT$126.85 Million | NT$224.11 Million | NT$97.58 Million | ▲ +103.3% |
| 2023 | 0.28x | NT$100.49 Million | NT$360.95 Million | NT$71.80 Million | ▼ -69.0% |
| 2022 | 0.90x | NT$249.07 Million | NT$276.93 Million | NT$114.71 Million | ▲ +186.9% |
| 2021 | 0.31x | NT$87.05 Million | NT$277.64 Million | NT$42.31 Million | ▲ +159.6% |
| 2020 | 0.12x | NT$30.02 Million | NT$248.55 Million | NT$8.72 Million | ▼ -89.7% |
| 2019 | 1.17x | NT$321.45 Million | NT$274.48 Million | NT$32.80 Million | ▼ -31.1% |
| 2018 | 1.70x | NT$250.81 Million | NT$147.46 Million | NT$15.96 Million | ▲ +577.2% |
| 2017 | 0.25x | NT$36.46 Million | NT$145.18 Million | NT$25.46 Million | ▲ +290.5% |
| 2016 | 0.06x | NT$16.10 Million | NT$250.35 Million | NT$16.10 Million | — |